GO:0042104 positive regulation of activated T cell proliferation: Immune Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042104 describes any process that activates or increases the rate or extent of proliferation of already activated T cells.
• The term is a biological process child of positive regulation of T cell proliferation and is distinct from initial T cell activation.
• Key positive regulators include IL-2 signaling, TCR co-stimulation, metabolic checkpoints such as glutaminolysis and lipid synthesis, and transcription factors that sustain effector expansion.
• Dysregulation of this process contributes to autoimmunity, allergy, transplant rejection, and cancer immune evasion.
• Experimental dissection relies on CRISPR knockout, point-mutation, knock-in, and overexpression models combined with proliferation assays, RNA-seq, and metabolic profiling.
• The term is best studied with functional readouts such as CFSE dilution, EdU incorporation, and cytokine production in primary human or murine T cells.
Description
GO:0042104, positive regulation of activated T cell proliferation, is a Gene Ontology biological process term that captures any molecular event that increases the rate or extent of proliferation of T cells that have already received an activating signal. This term is not about the initial activation of naive T cells but about the subsequent expansion of activated T cells, a critical step in adaptive immunity that determines the magnitude and duration of an immune response. Researchers studying infection, vaccination, autoimmunity, and cancer immunotherapy need to understand this process because the number of effector T cells generated after activation directly correlates with protective immunity or immunopathology. The QuickGO definition states: Any process that activates or increases the rate or extent of activated T cell proliferation. This definition places the term downstream of T cell activation and upstream of effector differentiation, making it a hub for signals that integrate antigen receptor strength, co-stimulation, cytokine availability, and metabolic fitness. Because activated T cell proliferation is energetically demanding, it is tightly coupled to nutrient uptake and mitochondrial metabolism, and perturbations in these pathways can either enhance or suppress the response. The term also encompasses negative feedback mechanisms that prevent excessive expansion, and its dysregulation is implicated in diseases ranging from autoimmunity to cancer.
positive regulation of activated T cell proliferation At A Glance
| GO ID | GO:0042104 |
|---|---|
| GO term | positive regulation of activated T cell proliferation |
| Ontology | biological_process |
| Synonym | activation of activated T cell proliferation; positive regulation of activated T-cell proliferation; positive regulation of activated T lymphocyte proliferation; positive regulation of activated T-lymphocyte proliferation; stimulation of activated T cell proliferation; up regulation of activated T cell proliferation; up-regulation of activated T cell proliferation; upregulation of activated T cell proliferation |
| Major function | Increases the rate or extent of proliferation of activated T cells, thereby expanding effector T cell populations. |
| Parent term | positive regulation of T cell proliferation |
| Related process | T cell activation, effector T cell differentiation, cytokine signaling, metabolic reprogramming |
| Cellular context | Occurs in activated CD4+ and CD8+ T cells in lymphoid organs and peripheral tissues |
| Disease relevance | Autoimmunity, allergy, transplant rejection, cancer immune evasion |
What Is GO:0042104?
In your own words, GO:0042104 refers to any biological process that stimulates or enhances the proliferation of T cells that are already activated. It includes signals from cytokines, co-stimulatory receptors, metabolic pathways, and transcription factors that drive cell-cycle entry and division in activated T cells, but it excludes the initial activation events that convert naive T cells into activated ones.
Why Is positive regulation of activated T cell proliferation Important in Cell Biology?
Understanding positive regulation of activated T cell proliferation is essential because the clonal expansion of activated T cells determines the strength and durability of adaptive immune responses. This process is a central checkpoint in vaccine-induced immunity, cancer immunotherapy, and autoimmune pathology, and it is a major target for therapeutic modulation. Moreover, the metabolic and signaling pathways that control this process are frequently hijacked in disease, making it a rich source of candidate drug targets and biomarkers.
• Determines the magnitude of effector T cell expansion after antigen encounter.
• Controls the balance between protective immunity and immunopathology.
• Is a key mechanism in autoimmune diseases such as multiple sclerosis and type 1 diabetes.
• Contributes to allergy and drug hypersensitivity through excessive T cell activation.
• Is targeted by tumors to evade immune destruction, for example via PD-L1 upregulation.
• Is required for effective cancer immunotherapy and adoptive T cell therapy.
• Is coupled to metabolic pathways such as glutaminolysis and lipid synthesis.
• Is regulated by microRNAs that fine-tune T cell responses.
• Provides a readout for immunotoxicity in drug development.
• Offers opportunities for CRISPR-based functional genomics to identify novel regulators.
What Happens During positive regulation of activated T cell proliferation?
Integration of activation and co-stimulatory signals
In simple terms: Activated T cells need a second push from co-stimulatory molecules and cytokines to start dividing.
After T cell receptor engagement, activated T cells require additional signals to enter the cell cycle. Co-stimulation through CD28 and cytokine signals such as IL-2 provide these positive regulators, which increase the rate of proliferation. The integration of these signals ensures that only appropriately activated T cells expand, and it is a key node for positive regulation.
Cytokine-driven proliferation
In simple terms: Cytokines like IL-2 act as growth factors that tell activated T cells to multiply.
IL-2 and related cytokines bind to their receptors on activated T cells and trigger JAK-STAT and PI3K-AKT signaling, which promotes cell-cycle progression and survival. This cytokine-driven expansion is a canonical example of positive regulation of activated T cell proliferation.
Metabolic reprogramming for proliferation
In simple terms: Dividing T cells need extra energy and building blocks, so they switch their metabolism.
Activated T cells undergo metabolic reprogramming to support rapid proliferation. Glutaminolysis and lipid synthesis are required for this process, and their positive regulation enhances proliferation. For example, pantothenate kinase 4 modulates coenzyme A and glutaminolysis to control lipid synthesis for T cell proliferation. Vitamin D supports activated CD4+ T cell proliferation through enhanced glutaminolysis.
Transcriptional control of effector expansion
In simple terms: Transcription factors turn genes on or off to drive the expansion of effector T cells.
Transcriptional programs orchestrate the differentiation and expansion of effector and memory CD8 T cells. Positive regulators include transcription factors that sustain proliferation and effector function, while negative regulators prevent excessive expansion. This transcriptional diversity allows fine-tuning of the proliferative response.
Regulation by microRNAs and signaling modulators
In simple terms: Small RNA molecules and signaling proteins can dial the proliferation up or down.
MicroRNAs are upregulated in drug-specific CD4+ T cells from hypersensitive patients and can modulate activation and proliferation. Additionally, differentially activated p38 counter-regulates T cell effector function, illustrating that positive regulation is balanced by negative feedback. These layers of regulation ensure appropriate T cell expansion.
Key Genes Involved in GO:0042104 positive regulation of activated T cell proliferation
The following genes and proteins are experimentally implicated in positive regulation of activated T cell proliferation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2 | Cytokine that promotes activated T cell proliferation | Central positive regulator; target for immune modulation |
| IL2RA | High-affinity IL-2 receptor subunit | Marker of activated T cells; modulates proliferation |
| CD28 | Co-stimulatory receptor | Provides second signal for activated T cell proliferation |
| TGFB1 | Cytokine with context-dependent effects | Regulates T cell proliferation and differentiation |
| PANK4 | Pantothenate kinase 4; modulates CoA and glutaminolysis | Controls lipid synthesis for T cell proliferation |
| VDR | Vitamin D receptor | Supports activated CD4+ T cell proliferation via glutaminolysis |
| GRN | Progranulin; induces PD-L1 on TAMs | Promotes CD8+ T cell exclusion in breast cancer |
| PDCD1 | PD-1; inhibitory receptor | Limits activated T cell proliferation; target in cancer therapy |
| CD274 | PD-L1; ligand for PD-1 | Upregulated by progranulin; suppresses T cell proliferation |
| MAPK14 | p38 MAPK; differentially activated | Counter-regulates T cell effector function |
| MIRNAs | MicroRNAs upregulated in drug-specific T cells | Modulate T cell activation and proliferation |
| TCF7 | Transcription factor for memory T cells | Regulates effector and memory differentiation |
| PRDM1 | Blimp-1; transcriptional repressor | Controls effector T cell differentiation |
| ID2 | Transcription factor | Influences effector and memory CD8 T cell fate |
| BATF | Transcription factor | Promotes effector T cell differentiation |
| IRF4 | Transcription factor | Regulates effector T cell expansion |
| STAT5 | Signal transducer downstream of IL-2 | Mediates cytokine-driven proliferation |
| MTOR | Kinase integrating nutrient and growth signals | Central regulator of T cell proliferation and metabolism |
How Is positive regulation of activated T cell proliferation Regulated?
Positive regulation of activated T cell proliferation is controlled by a network of extracellular cues and intracellular pathways. Cytokines such as IL-2 activate JAK-STAT and PI3K-AKT-mTOR signaling to drive proliferation. Metabolic inputs, including glutaminolysis and lipid synthesis, are required and are modulated by enzymes such as PANK4 and by vitamin D signaling. Negative feedback is provided by inhibitory receptors like PD-1 and by differentially activated p38, which counter-regulates effector function. MicroRNAs also fine-tune the response by targeting transcripts involved in activation and proliferation. Transcriptional regulators such as TCF7, PRDM1, ID2, BATF, and IRF4 shape the effector and memory programs that emerge from proliferating activated T cells.
positive regulation of activated T cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL2 | Autoimmunity, transplant rejection | IL2 knockout mice; T cell proliferation assays |
| PANK4 | Metabolic control of T cell proliferation | PANK4 knockout Jurkat or primary T cells |
| VDR | Vitamin D deficiency and impaired T cell proliferation | VDR knockout CD4+ T cells; glutaminolysis assays |
| GRN | Breast cancer immune evasion | Progranulin-overexpressing tumor models; T cell co-culture |
| MAPK14 | T cell effector counter-regulation | p38 knockout or point-mutant T cells |
Autoimmunity and chronic inflammation
Excessive positive regulation of activated T cell proliferation can lead to autoimmunity, as sustained expansion of self-reactive T cells drives tissue damage. TGF-β signaling is a critical regulator of T cell proliferation and differentiation, and its dysregulation is linked to autoimmune pathology. Targeting pathways that positively regulate activated T cell proliferation is a therapeutic strategy in autoimmune diseases.
Cancer immune evasion
Tumors can suppress activated T cell proliferation to evade immune destruction. Progranulin induces PD-L1 expression on tumor-associated macrophages and promotes CD8+ T cell exclusion in breast cancer, thereby limiting T cell proliferation and effector function. Blocking this pathway restores T cell proliferation and enhances anti-tumor immunity.
Drug hypersensitivity and allergy
Drug-specific CD4+ T cells from hypersensitive patients show upregulation of activation microRNAs, which can enhance T cell activation and proliferation. This dysregulated positive regulation contributes to allergic reactions and provides biomarkers for drug hypersensitivity.
Metabolic disorders and immune function
Metabolic pathways that support activated T cell proliferation, such as glutaminolysis and lipid synthesis, are altered in obesity and diabetes, affecting immune responses. Vitamin D deficiency, for example, impairs activated CD4+ T cell proliferation through reduced glutaminolysis. Understanding these links may inform nutritional and pharmacological interventions.
From positive regulation of activated T cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate activated T cell proliferation? | CRISPR knockout in primary human or murine T cells followed by CFSE dilution |
| Does a specific point mutation in gene X alter proliferation? | CRISPR point-mutation knock-in in Jurkat or primary T cells |
| Does tagging gene X affect its function in proliferation? | CRISPR knock-in of fluorescent or epitope tag |
| Does overexpression of gene X enhance proliferation? | Lentiviral overexpression in activated T cells |
| Which metabolic pathways are required for proliferation? | CRISPR knockout of metabolic genes combined with Seahorse and glutaminolysis assays |
| How do microRNAs regulate activated T cell proliferation? | CRISPR knockout of miRNA loci or miRNA mimics in primary T cells |
How to Study the positive regulation of activated T cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CFSE dilution | Cell division history | Quantify activated T cell proliferation |
| EdU incorporation | DNA synthesis | Measure proliferation rate |
| RNA-seq | Transcriptome changes | Identify proliferation-associated genes |
| ATAC-seq | Chromatin accessibility | Map regulatory elements in activated T cells |
| Seahorse assay | Glycolysis and oxidative phosphorylation | Assess metabolic reprogramming |
| Glutamine uptake assay | Glutaminolysis activity | Evaluate metabolic dependencies |
| CRISPR knockout screen | Gene function at scale | Discover novel regulators of proliferation |
| Flow cytometry | Surface markers and cytokine production | Characterize activated T cell phenotypes |
Proliferation assays
CFSE or CellTrace Violet dilution, EdU incorporation, and 3H-thymidine uptake are standard methods to measure activated T cell proliferation. These assays quantify the rate and extent of division after activation and are used to validate positive regulators.
Transcriptomic and epigenetic profiling
RNA-seq and ATAC-seq of activated T cells can identify transcriptional programs and regulatory elements that drive proliferation. These methods reveal genes and pathways that are upregulated during positive regulation.
Metabolic profiling
Seahorse extracellular flux analysis, glutamine uptake assays, and lipidomics measure metabolic reprogramming that supports proliferation. Such methods have been used to show that PANK4 and vitamin D regulate glutaminolysis and lipid synthesis for T cell proliferation.
CRISPR screens and functional genomics
Pooled CRISPR knockout screens in primary T cells or cell lines can identify novel positive regulators of activated T cell proliferation. Hits are validated with individual knockouts and proliferation readouts.
How CRISPR Can Be Used to Study GO:0042104 positive regulation of activated T cell proliferation
Knockout
CRISPR knockout of candidate genes in primary T cells or Jurkat cells is used to test whether a gene is required for activated T cell proliferation. For example, knockout of PANK4 impairs lipid synthesis and proliferation, demonstrating its positive regulatory role. Knockout of metabolic genes followed by CFSE dilution provides causal evidence.
Point Mutation
CRISPR point-mutation knock-in allows precise modification of specific residues to test their role in signaling. For instance, mutating phosphorylation sites in p38 can reveal how differentially activated p38 counter-regulates T cell effector function. This approach is valuable for dissecting signaling nodes that control proliferation.
Knock-in
Knock-in of fluorescent or epitope tags enables tracking of endogenous proteins in activated T cells. Tagging transcription factors such as TCF7 or IRF4 can reveal their dynamics during proliferation and differentiation. This method preserves endogenous regulation and is ideal for studying dose-dependent effects.
Overexpression
CRISPR activation or lentiviral overexpression can test whether increasing a gene's activity enhances activated T cell proliferation. Overexpression of progranulin in tumor models promotes PD-L1 upregulation and T cell exclusion, indirectly suppressing proliferation. Conversely, overexpressing positive regulators such as IL-2 can boost proliferation.
How EDITGENE Supports positive regulation of activated T cell proliferation Research
Researchers studying positive regulation of activated T cell proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining T cell expansion. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of activated T cell proliferation research.
Frequently Asked Questions About positive regulation of activated T cell proliferation
What is GO:0042104?
GO:0042104 is the Gene Ontology term for positive regulation of activated T cell proliferation, defined as any process that activates or increases the rate or extent of proliferation of activated T cells.
What genes are involved in positive regulation of activated T cell proliferation?
Key genes include IL2, IL2RA, CD28, PANK4, VDR, GRN, PDCD1, CD274, MAPK14, and transcription factors such as TCF7, PRDM1, ID2, BATF, and IRF4.
How is activated T cell proliferation measured?
Common methods include CFSE dilution, EdU incorporation, and 3H-thymidine uptake, often combined with flow cytometry for surface markers and cytokine production.
What role does metabolism play in activated T cell proliferation?
Metabolic reprogramming, including enhanced glutaminolysis and lipid synthesis, is required for activated T cell proliferation; enzymes like PANK4 and vitamin D signaling support these pathways.
How does cancer evade T cell proliferation?
Tumors can upregulate PD-L1 on macrophages via progranulin, leading to CD8+ T cell exclusion and suppressed proliferation.
What is the difference between T cell activation and positive regulation of activated T cell proliferation?
T cell activation is the initial triggering of naive T cells, while positive regulation of activated T cell proliferation refers to processes that enhance the subsequent division of already activated T cells.
Which cytokines promote activated T cell proliferation?
IL-2 is a major cytokine that promotes activated T cell proliferation through JAK-STAT and PI3K-AKT signaling.
How do microRNAs affect activated T cell proliferation?
MicroRNAs are upregulated in drug-specific CD4+ T cells from hypersensitive patients and can modulate activation and proliferation.
What CRISPR models are used to study this process?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models in primary T cells or Jurkat cells are widely used to dissect positive regulators.
Why is positive regulation of activated T cell proliferation important in immunotherapy?
It determines the expansion of effector T cells that mediate anti-tumor responses, and modulating it can enhance or suppress immune reactions.
Conclusion
GO:0042104, positive regulation of activated T cell proliferation, is a central biological process that governs the expansion of effector T cells after activation. It integrates cytokine signals, co-stimulation, metabolic reprogramming, and transcriptional networks to determine immune response magnitude. Dysregulation of this process contributes to autoimmunity, allergy, cancer immune evasion, and metabolic immune disorders. CRISPR-based functional genomics, combined with proliferation and metabolic assays, offers powerful tools to identify and validate novel regulators. EDITGENE provides end-to-end services to support such research, from knockout and knock-in models to library screening and bioinformatics.
References
- 1. Chen W. 2023. TGF-β Regulation of T Cells.. Annu Rev Immunol 41:483-512 PMID: 36750317
- 2. Vera AA et al.. 2026. Vitamin D supports activated CD4(+) T-cell proliferation through enhanced glutaminolysis.. Front Immunol 17:1791098 PMID: 42367775
- 3. Fang W et al.. 2021. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion.. J Exp Clin Cancer Res 40(1):4 PMID: 33390170
- 5. Monroy-Arreola A et al.. 2018. Up-Regulation of T-Cell Activation MicroRNAs in Drug-Specific CD4(+) T-Cells from Hypersensitive Patients.. Chem Res Toxicol 31(6):454-461 PMID: 29644860
- 6. Alam MS et al.. 2014. Counter-regulation of T cell effector function by differentially activated p38.. J Exp Med 211(6):1257-70 PMID: 24863062
- 7. Hwang JR et al.. 2025. Pantothenate kinase 4 controls lipid synthesis for T-cell proliferation by modulating coenzyme A and glutaminolysis.. Signal Transduct Target Ther 10(1):302 PMID: 40962808
- 8. Rutishauser RL et al.. 2010. Generating diversity: transcriptional regulation of effector and memory CD8 T-cell differentiation.. Immunol Rev 235(1):219-33 PMID: 20536566
